Updated: J&J Moves Closer To PFA Approval; New Data Presented At Boston AF

The AF Symposium in Boston Featured presentations of two trials of Johnson & Johnson/Biosense Webster’s Varipulse pulsed field ablation system and more safety data from the ADVENT trial of Boston Scientific’s Farapulse PFA.

Cardiovascular Catch-Up
• Source: Shutterstock

More from Clinical Trials

More from R&D